SCHEMBL20045047

SCHEMBL20045047

CC(C)c1cccc(NC2CCN(C)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
KAT2B Q92831 1/20 0.40
HTR6 P50406 1/20 0.39
NOTUM Q6P988 1/20 0.39
IDH2 P48735 1/20 0.38
HTR1A P08908 1/20 0.37
HTR7 P34969 1/20 0.37
GFER P55789 1/20 0.37
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
UBE2M P61081 1/20 0.36
DCUN1D1 Q96GG9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25583705 0.91 POLB (0.50) POLBKDM4EHTR6IDH2HTR1A
SCHEMBL18466534 0.84 ALDH1A1 (0.42) KDM4ENOTUMNPC1ALDH1A1MAPT
SCHEMBL25897996 0.82 POLB (0.57) POLBGFERNPC1ALDH1A1MAPT
SCHEMBL12615267 0.81 GRIN2D (0.43) KDM4ENOTUMNPC1ALDH1A1MAPT
SCHEMBL21297240 0.81 ALDH1A1 (0.47) KDM4ENPC1ALDH1A1MAPTMAPK1
SCHEMBL15829991 0.81 SSTR1 (0.48) POLBKDM4EKAT2BHTR6NPC1
SCHEMBL19633530 0.80 MEN1 (0.44) KDM4EHTR1AHTR7ALDH1A1MAPT
SCHEMBL21297297 0.80 MEN1 (0.44) KDM4EHTR1AHTR7ALDH1A1MAPT
SCHEMBL24506826 0.79 RXFP1 (0.42) KDM4ENPC1ALDH1A1MAPTHTT
SCHEMBL11236449 0.78 CARM1 (0.55) POLBKAT2BHTR6CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180098987-A1 PRMT5 Inhibitors and Uses Thereof Epizyme, Inc. (US) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098987-A1 PRMT5 Inhibitors and Uses Thereof PRMT5, PRMT1, PRMT6 POLB 2005/4885KDM4E 36/4885KAT2B 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.